Daily Market Recap: October 28, 2025

The Nasdaq‐listed small‐cap sector staged a dramatic rebound on October 28, driven by telehealth approvals, platform rollouts and renewed investor interest in biotech and event‐planning plays. All 18 monitored tickers posted double-digit gains, with several names more than doubling on heavy volume. Below is a summary of today’s trading activity.

Trading Summary

Ticker	ATTN Price	Current Price	Volume	Price Change %
VSEE	0.3638	0.9855	171,443,920	170.97%
XHLD	0.1489	0.3700	465,837,356	148.62%
CODX	0.3224	0.5541	41,888,836	71.93%
FRGT	0.8052	1.3100	55,426,481	62.70%
CCJ	95.70	107.50	13,927,033	12.40%
IPDN	1.9880	2.9101	4,679,569	46.43%
CLS	288.40	326.00	4,117,195	13.02%
LUNG	1.1515	1.8799	70,779,808	63.28%
CTOS	5.3540	6.0200	1,188,904	12.43%
ARQT	21.4410	25.0882	8,923,557	17.05%
RVYL	0.2031	0.3480	56,913,605	71.29%
W	94.79	106.50	9,800,815	12.37%
BYND	1.4736	1.9100	349,146,249	29.67%
FGL	0.3100	0.4931	88,178,662	59.14%
ADTX	0.0677	0.1286	83,353,162	89.90%
TDIC	0.2773	0.5200	18,807,507	87.50%
VRA	1.9158	2.4983	1,578,371	30.41%
BLMZ	0.1237	0.1940	25,165,816	56.79%

Market Trends and Patterns

Today’s session was characterized by broad‐based rallies in telehealth, biotech diagnostics and event‐planning stocks, spurred by regulatory approvals, platform enhancements and strategic partnerships. Volume surged across the board, with XHLD and BYND each trading over 300 million shares. High‐beta names led the advance:

• Telehealth: VSEE rocketed 170.97% after securing FedRAMP High ATO approval and announcing new federal contracts.
• Event‐Planning: XHLD jumped 148.62% on pre-conference investor enthusiasm and plans to roll out a PaaS model.
• Diagnostics & Biotech: CODX, RVYL and FGL all climbed more than fifty percent amid new assay approvals and JV expansions in Asia and the Middle East.

Meanwhile, established names such as Cameco (CCJ) and Wolters Kluwer (W) saw more modest, yet still significant, gains of around 12% on rising commodity prices and strong earnings forecasts, respectively.

Telehealth by National Cancer Institute

Significant Movers

VSee Health (VSEE) once again topped the leaderboard, more than doubling as institutional investors piled in on expectations of accelerated federal deployments. Similarly, TEN Holdings (XHLD) benefited from pre-IPO conference buzz and a technology upgrade roadmap. On the diagnostic front, Co-Diagnostics (CODX) and Revival Gold Mining (RVYL) both posted near-72% gains after announcing equity raises tied to global partnerships.

Smaller caps like ADTX and TDIC surged nearly 90% on speculative momentum fueled by upbeat management commentary and robust trading volumes above 80 million shares. Even legacy players such as CCJ and CLS saw double-digit lifts as commodity markets and enterprise software budgets remain healthy.

TL;DR

• The small-cap roster rallied hard on October 28, led by telehealth and biotech plays.
• VSEE (+170.97%) and XHLD (+148.62%) saw the biggest gains, driven by FedRAMP approval and PaaS platform rollouts.
• Heavy volume accompanied broad double-digit advances, with 14 of 18 names up more than 30%.